Thursday, October 22, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· October 16, 2026

Palantir Technologies declines 7% amid broader tech selloff

View original at seekingalpha.com
Palantir Technologies declines 7% amid broader tech selloff [Palantir Technologies headquarters campus exterior view in Silicon Valley…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Remains constructive on Palantir. Emphasizes customer expansion and net dollar retention as central to the bull case, while acknowledging that the elevated forward valuation makes continued execution essential.

    60% confidence
  • Upgraded Palantir to Buy after concluding that customer-built AI applications can remain complementary to Palantir's platforms rather than displace its core offering.

    60% confidence
  • Strongly bullish on Palantir. Points to government awards, Maven deployments, larger customer deals and operating leverage as evidence that consensus estimates underestimate its earnings potential.

    60% confidence
  • Reiterates a bullish rating on Palantir, citing the Goldman Sachs upgrade, AI-platform adoption, commercial growth, profitability and technical momentum. Flags valuation, customer concentration and share dilution as risks.

    60% confidence
  • Bullish growth-investor case centered on Palantir's secure private AI environments, revenue growth, operating leverage and free cash flow, while cautioning that the valuation may already reflect much of the expected enterprise-AI opportunity.

    60% confidence
  • Bullish on Palantir. Highlights customer expansion, net dollar retention, remaining deal value and expected earnings growth. Names high valuation, dilution, customer concentration and competition as the primary risks.

    60% confidence
  • Bearish on Palantir. Argues its current valuation requires capturing an exceptionally large share of its addressable market and that it faces competitive pressure from large technology companies delivering related functionality through existing cloud products.

    60% confidence
  • Upgraded Palantir from Neutral to Buy, citing recent underperformance and the prospect of another growth phase driven by sovereign AI, customized applications, and Palantir's forward-deployed engineering model.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Crunch: Late-Stage Readouts and Regulatory Milestones Converge on the Ivonescimab PDUFA Date
October 2026 is dense with clinical and regulatory news. Phase 3 trials hit primary endpoints (ALOFT-IPF, RESTORE-3), long-term data came out (MIUDELLA at 6 years, QUILT-3.032), and the FDA accepted Roche's vamikibart BLA. Scholar Rock resubmitted its apitegromab MAA to the EMA. The next catalysts are ESMO 2026 (Oct 23) and the Nov 14 FDA PDUFA date for ivonescimab, followed by Maritime-1 primary completion in January 2027. The speculative QAIAx items (QIII pilot, microcities patent) are a weak, tangential thread with little financial substance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,426 source documents archived
Query this data → isubstrate.com